3% cell suspensions for the screening and identification of red cell antibodies in human serum and plasma
General information All cell suspensions are derived from individual donors possessing blood group O. The screening cells consist of 10 ml vials. The identification panel cells and the Wra positive cell consist of 3 ml vials. The cells are suspended in a preservation medium. These cell suspensions meet the requirements of the concerned standards and guidelines. Performance characteristics are mentioned in the release documents, which are supplied with the product upon request. The principle of the test is the agglutination technique, which is based on antigen/antibody reaction. The cells can be used to screen for and/or identify red cell antibodies in human serum or plasma in various techniques (e.g. in the indirect antiglobulin test with BSA 22% ( K1106) or BSA 30% ( K1107), PeliLISS ( K1110) or PEG 4000 20% ( K1159). Antigen profile sheet An antigen profile sheet is included with every panel except the Wra positive cells. Shaded columns in the sheet indicate antigens destroyed or diminished in reactivity by enzyme treatment. Presence or absence of the antigens marked with * on the sheet may have been determined with a single source of the specific antibody directed against this particular antigen.